Belgija - angleščina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

amdipharm ltd. - chlortalidone 50 mg - tablet - 50 mg - chlortalidone 50 mg - chlortalidone

Belgija - angleščina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sankyo pharma belgium sa-nv - chlortalidone 25 mg; metoprolol tartrate 200 mg - prolonged-release tablet - 200 mg - 25 mg - chlortalidone 25 mg; metoprolol tartrate 200 mg - chlortalidone; c07ab02 metoprolol; c07cb02 metoprolol and other diuretics

Velika Britanija - angleščina - MHRA (Medicines & Healthcare Products Regulatory Agency)

dhp healthcare ltd - chlortalidone; triamterene - oral tablet - 50mg ; 50mg

Velika Britanija - angleščina - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - chlortalidone; triamterene - oral tablet - 50mg ; 50mg

Velika Britanija - angleščina - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - chlortalidone; triamterene - oral tablet - 50mg ; 50mg

Irska - angleščina - HPRA (Health Products Regulatory Authority)

geigy pharmaceuticals - chlortalidone potassium chloride - tablets - 25 milligram

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - amiloride hydrochloride dihydrate 5mg;  ; hydrochlorothiazide 50mg - tablet - 50mg/5mg - active: amiloride hydrochloride dihydrate 5mg   hydrochlorothiazide 50mg excipient: calcium hydrogen phosphate guar gum lactose magnesium stearate maize starch pregelatinised maize starch sunset yellow fcf - moduretic is indicated in the treatment of patients with: - oedema of cardiac origin; - hepatic cirrhosis with ascites; - hypertension in whom potassium depletion might be anticipated. moduretic, with its combination of amiloride hcl and hydrochlorothiazide, minimises the possibility of the development of excessive potassium loss in patients during vigorous diuresis for prolonged periods. moduretic, with its built-in potassium sparing agent, is especially indicated in those conditions where the positive effect on potassium balance is particularly important. moduretic may be used alone, or as an adjunct to other antihypertensive drugs. since it enhances the action of these agents, the dosage of these antihypertensive drugs may need to be reduced to avoid the risk of an excessive drop in blood pressure.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - chlortalidone, quantity: 25 mg - tablet, uncoated - excipient ingredients: purified talc; iron oxide yellow; iron oxide red; colloidal anhydrous silica; lactose monohydrate; maize starch; magnesium stearate - indications as at 19 november 1996: essential arterial hypertension, as long as creatinine clearance is >30 ml/min; as primary therapy or in combination with other antihypertensive agents; stable, chronic heart failure of mild to moderate degree (functional class ii, iii), as long as creatinine clearance is >30ml/min; ascites due to cirrhosis of the liver in stable patients under close control.

Irska - angleščina - HPRA (Health Products Regulatory Authority)

rowex ltd - chlortalidone; atenolol - film-coated tablet - 100 mg/25 milligram(s) - beta blocking agents, selective, and other diuretics; atenolol and other diuretics

Irska - angleščina - HPRA (Health Products Regulatory Authority)

rowex ltd - chlortalidone; atenolol - film-coated tablet - 50 mg/12.5 milligram(s) - beta blocking agents, selective, and other diuretics; atenolol and other diuretics